"The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder." His team published its findings Feb. 12 in JAMA ...

In one study of GLP-1 drugs (but not Ozempic specifically), females were almost eight times more likely to report headache than males. In the same study, females were about 3.5 times more likely ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

The quick answer is that dosing for semaglutide varies by whether you take Ozempic ... starts with 0.2mg in the first month and progresses to 0.75mg during month three and 1.25mg in month six.

Yes, some Ozempic side effects may be more common in females vs. males. However, most of the research to date has focused on the side effects of GLP-1 receptor agonists in general (the class of ...

Patients on semaglutide (Ozempic, Wegovy) had a 32% increased relative ... increased risk for NAION compared with other GLP-1 diabetes medications. More research is needed to confirm this link ...

Compounding pharmacies and telehealth companies selling lower-cost versions of Novo Nordisk's Ozempic and Wegovy will ... Compounding pharmacies and brand-name GLP-1 manufacturers have long ...